34 research outputs found
Annual event rate on each randomized regimen.
<p>Annual event rate on each randomized regimen.</p
Estimated annual event rates for myocardial infarction and stent thrombosis in the short-DAPT group during aspirin mono-therapy.
<p>The landmark data was not available for myocardial infarction in the RESET and EXCELLENT trials. NA = not available.</p
Forest plot with OR of prolonged-DAPT relative to short-DAPT for each clinical outcome for the DAPT trial and the pooled population excluding the DAPT trial.
<p>ORs are shown on a logarithmic scale. CI = confidence interval, DAPT = dual anti-platelet therapy, and OR = odds ratio.</p
Fig 2 -
Crude kaplan-meier curves for the cumulative incidence of (A) all-cause death/MI/stroke, (B) all-cause death, (C) any coronary revascularization, and (D) all-cause death/MI/stroke/any coronary revascularization. PCI = percutaneous coronary intervention; CABG = coronary artery bypass grafting; MI = myocardial infarction.</p
Baseline characteristics, medications, angiographic and procedural characteristics during the index hospitalization in the propensity score-matched cohort.
(DOCX)</p
Subgroup analyses for the primary outcome measure (death/MI/stroke).
Subgroup analyses for the primary outcome measure (death/MI/stroke).</p
Kaplan-Meier event curves for clinical outcomes in patients with two-vessel or three-vessel disease including proximal LAD.
(TIF)</p
Clinical outcomes: PCI group versus CABG group in patients with two-vessel disease who underwent multi-vessel revascularization including LAD.
(DOCX)</p